Abstract |
Some dentists propose administering botulinum neurotoxin injections to treat orofacial pain. The scientific literature has documented there are dangerous uncontrollable effects of long-distance traveling of botulinum neurotoxin from the injection site. These distant effects are not technique-specific, not predictable, and cannot be controlled by the amount of neurotoxin, nor by the site administered. These uncontrollable distant effects of "off-label" botulinum neurotoxin injections, at the very least, must be thoroughly disclosed to patients.
|
Authors | Joseph Schames, Y Dov Prero, David Schames, Mayer Schames, William Gabriel, Robert Reed |
Journal | Journal of the California Dental Association
(J Calif Dent Assoc)
Vol. 37
Issue 1
Pg. 44-5
(Jan 2009)
ISSN: 1043-2256 [Print] United States |
PMID | 19263628
(Publication Type: Journal Article)
|
Chemical References |
- Cholinergic Antagonists
- Neuromuscular Agents
- Synaptosomal-Associated Protein 25
- Botulinum Toxins, Type A
|
Topics |
- Botulinum Toxins, Type A
(adverse effects, pharmacology)
- Cholinergic Antagonists
(pharmacology)
- Deglutition Disorders
(chemically induced)
- Facial Pain
(drug therapy)
- Humans
- Neuromuscular Agents
(adverse effects, pharmacology)
- Peripheral Nervous System Diseases
(chemically induced)
- Synaptosomal-Associated Protein 25
(antagonists & inhibitors)
|